Actos – FDA Issues Drug Safety Announcement Concerning Bladder Cancer
The Food and Drug Administration (FDA) announced on December 7, 2011, that it would be conducting a safety review of the drug Pradaxa, which is used to treat a common type of heart rhythm abnormality. The study focuses around the possible increased risk of bleeding for Pradaxa patients. For a demonstration of how Pradaxa can…
Free Case Evaluation